Please login to the form below

Not currently logged in
Email:
Password:

Cellectis appoints Dr Loan Hoang-Sayag as chief medical officer

She joins the biopharma company from Quintiles

New York-based Cellectis has appointed Dr Loan Hoang-Sayag at its chief medical officer.

She will be responsible for bringing Cellectis' product candidates into clinical stage development as well as strategic and operational management of the company's therapeutic activities.

Dr Hoang-Sayag joins Cellectis after 10 years at Quintiles where she most recently held the role of senior director of medical science.

She has over 20 years of experience in haematology and medical oncology, and prior to Quintiles held positions at Pierre Fabre Oncology and Hoffman La Roche.

Dr André Choulika, chairman and chief executive officer of Cellectis, said: “Dr Hoang-Sayag's experience in oncology clinical development - specifically in strategy and delivery in all phases in the pharmaceutical, biotechnology and clinical research spaces - enables her to lead Cellectis' strategy and generate awareness around the breakthrough work that we are doing as a leader and innovator in the field.”

Dr Hoang-Sayag will report directly to executive vice president and chief operating officer, Mathieu Simon.

Simon said: “Dr Hoang-Sayag's impressive and extensive professional background makes her a perfect fit for the Cellectis team, as her clinical development expertise will play a key role in helping us to achieve our goals and strategic priorities in 2016 and beyond.”

12th January 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics